CD8A and melanoma: Such an impaired cytotoxic function and the modulation of the immunoregulatory profile have also been described for other antitumor effectors, in particular NK and CD8 T cells, in the blood of melanoma patients compared with HDs and in metastatic regional lymph nodes compared with non-metastatic lymph nodes (39, 40).